Competitive Intelligence, Diseases 0 Comments

Summarized clinical trials landscape for colorectal cancer as on 27th dec 2016. Data source: clinicaltrials.gov Clinical trials intelligenceBy: TrialsFind PRO Colorectal cancer clinical trials overview 1166 open studies for Colorectal cancer. 12% of trials are in phase 1. 27% of trials are in phase 2. 14% of trials are in phase 3. 2% of trials

Read More

Competitive Intelligence, Diseases 0 Comments

Summarized clinical trials landscape for non-small cell lung cancer as of 26th dec 2016. Data source: clinicaltrials.gov Clinical trials intelligence By: TrialsFind PRO NSCLC clinical trials overview Of the 15257 open cancer studies on clinicaltrials.gov, 988 (6.5%) are studies for NSCLC. Merck, Novartis and Astrazeneca are the most active industry players in NSCLC. 19% of

Read More